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Abstract
Background: Two-dimensional (2D) perfusion cardiovascular magnetic resonance (CMR) remains limited by a lack of
complete myocardial coverage. Three-dimensional (3D) perfusion CMR addresses this limitation and has recently
been shown to be clinically feasible. However, the feasibility and potential clinical utility of quantitative 3D perfusion
measurements, as already shown with 2D-perfusion CMR and positron emission tomography, has yet to be evaluated.
The influence of systolic or diastolic acquisition on myocardial blood flow (MBF) estimates, diagnostic accuracy and
image quality is also unknown for 3D-perfusion CMR. The purpose of this study was to establish the feasibility of
quantitative 3D-perfusion CMR for the detection of coronary artery disease (CAD) and to compare systolic and
diastolic estimates of MBF.
Methods: Thirty-five patients underwent 3D-perfusion CMR with data acquired at both end-systole and
mid-diastole. MBF and myocardial perfusion reserve (MPR) were estimated on a per patient and per territory
basis by Fermi-constrained deconvolution. Significant CAD was defined as stenosis ≥70% on quantitative
coronary angiography.
Results: Twenty patients had significant CAD (involving 38 out of 105 territories). Stress MBF and MPR had a high
diagnostic accuracy for the detection of CAD in both systole (area under curve [AUC]: 0.95 and 0.92, respectively) and
diastole (AUC: 0.95 and 0.94). There were no significant differences in the AUCs between systole and diastole
(p values >0.05). At stress, diastolic MBF estimates were significantly greater than systolic estimates (no CAD: 3.21 ± 0.50
vs. 2.75 ± 0.42 ml/g/min, p < 0.0001; CAD: 2.13 ± 0.45 vs. 1.98 ± 0.41 ml/g/min, p < 0.0001); but at rest, there were
no significant differences (p values >0.05). Image quality was higher in systole than diastole (median score 3 vs. 2,
p = 0.002).
Conclusions: Quantitative 3D-perfusion CMR is feasible. Estimates of MBF are significantly different for systole and
diastole at stress but diagnostic accuracy to detect CAD is high for both cardiac phases. Better image quality suggests
that systolic data acquisition may be preferable.
Keywords: Cardiovascular magnetic resonance, Perfusion, 3-dimensional, Myocardial perfusion imaging, Ischemic heart
disease, Myocardial blood flow
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Background
Myocardial perfusion imaging with cardiovascular mag-
netic resonance (CMR) is a highly accurate technique
for the detection of coronary artery disease (CAD) [1].
However, conventional acquisition with two-dimensional
(2D) methods can only acquire a small number of non-
contiguous slices of the left ventricle (LV) at each R-R
interval, and therefore incomplete myocardial coverage
remains a significant limitation.
Recent technological advances have allowed unprece-
dented acceleration of dynamic CMR and have led to
the development of three-dimensional (3D) myocardial
perfusion CMR methods providing full LV coverage with
preserved temporal and spatial resolution [2-4]. Three
recent studies have shown 3D-perfusion CMR to be clin-
ically feasible and highly accurate for the detection of
CAD with visual perfusion assessment [5-7]. However, the
feasibility and potential clinical application of deriving
quantitative estimates of myocardial blood flow (MBF)
from 3D-perfusion CMR has not yet been studied.
A further limitation of conventional 2D-perfusion CMR
is that each slice is acquired in a different period of the
cardiac cycle. Two recent quantitative studies have shown
a significant difference in MBF estimates derived from the
same mid-ventricular slice acquired in systole and diastole
with 2D-perfusion CMR [8,9]. As well as limiting quanti-
tative comparisons between slices, these significant phasic
differences impact on inter-study and longitudinal compar-
isons of MBF. Unlike 2D-perfusion CMR, 3D imaging al-
lows acquisition of data from the entire myocardium in the
same, optimised period of the cardiac cycle. Most previous
3D-perfusion CMR studies have acquired data in systole
but to date it is unknown whether systolic or diastolic
acquisition leads to better image quality and diagnostic
yield. Furthermore, it is unknown whether quantitative es-
timates of MBF from 3D data demonstrate the same phasic
differences previously reported for 2D techniques [8,9].
The purpose of this study was therefore to estab-
lish the feasibility of quantitative 3D-perfusion CMR for
the detection of coronary artery disease (CAD) and to
compare systolic and diastolic estimates of MBF. Defin-
ing the optimal cardiac phase for acquisition may be
more relevant for 3D than 2D-perfusion CMR because
it allows the acquisition of all slices in a particular cardiac
phase.
Methods
Population
Forty consecutive patients with known or suspected
CAD were recruited. All patients were imaged within
30 days of clinically scheduled diagnostic coronary angi-
ography. No revascularization or clinical events occur-
red between angiography and CMR. Exclusion criteria
were contraindications to CMR, adenosine, or gadolinium
contrast agents, recent myocardial infarction (MI) or
unstable angina (within 6 months), or poorly controlled
arrhythmias. Patients were instructed to refrain from caf-
feine for 24 hours before their CMR study but continue
cardiac medications as normal. The study was approved
by the regional ethics committee and all patients gave
written consent.
CMR protocol
All studies were performed on a 3.0 T scanner (Achieva
TX, Philips Healthcare, Best, The Netherlands) equipped
with dual-source parallel radiofrequency transmission tech-
nology and a 32-channel cardiac coil. For perfusion im-
aging, a 3D spoiled turbo gradient-echo sequence was used
(TR/TE/flip angle 1.8 ms/0.7 ms/15°; saturation prepulse
delay 150 ms; linear k-space encoding; 70% partial Fourier
acquisition in two dimensions; typical field of view 350 ×
350 mm; 10 fold k-t acceleration and 11 training profiles
leading to a net acceleration of 7.0; typical acquisition
duration 192 ms, k-t principal component analysis (PCA)
reconstruction; reconstructed to 12 contiguous slices with
voxel size 2.3×2.3×5 mm3) [2,7].
Two k-t undersampled 3D data sets were acquired in
each R-R interval, each preceded by a non-selective sat-
uration prepulse. Vertical and horizontal long-axis cine
images were used to identify appropriate trigger delays
for systolic and diastolic acquisition [8-10]. Additionally,
because of the longitudinal lengthening of the heart
from systole to diastole, the position of the end-systolic
and mid-diastolic perfusion stacks (12 slices each) were
individually planned from the chosen systolic and dias-
tolic cine frames (Figure 1) [8,9]. The same trigger delays
were used for stress and rest acquisitions.
Stress perfusion images were acquired during intraven-
ous adenosine-induced hyperemia administered for 4 min
at 140mcg/kg/min. Consistent with previous 3D-perfusion
CMR studies, an intravenous bolus of 0.075 mmol/kg of
gadobutrol (Gadovist, Bayer Schering Pharma, Berlin,
Germany) was administered at a rate of 4.0 ml/s followed
by a 20 ml saline flush. Stress perfusion CMR was followed
by cine imaging covering the left ventricle in 10-12 short-
axis sections. Rest perfusion CMR was performed 15 min
after stress, using identical imaging parameters. Late gado-
linium enhancement (LGE) imaging was acquired in the
same short-axis geometry as perfusion imaging after an
additional 10-15 min using conventional 2D methods (T1
weighted segmented inversion recovery gradient echo; TR/
TE/flip angle 4.9 ms/1.9 ms/15°; inversion time individually
adjusted according to Look-Locker scan; spatial resolution
1.35 × 1.35 × 10 mm).
Image quality
Systolic and diastolic perfusion images were analyzed in
separate reporting sessions in random order (MM, 2 years
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experience of perfusion CMR). Overall image quality was
scored as follows: 0 = non-diagnostic, 1 = poor, 2 =
adequate and 3 = excellent. The occurrence of artifact
related to respiratory-motion, k-t reconstruction or dark-
rim artifact was scored as follows: 0 = none, 1 = mild,
2 = moderate and 3 = severe.
Myocardial blood flow estimation
Perfusion images were processed offline using previously
validated in-house software (PMI 0.4; written in IDL 6.4
(ITT Visual Information Systems, Boulder, CO) [11]. All
short-axis slices with clearly identifiable LV cavity enhance-
ment during first-pass perfusion and with >75% circumfer-
ential LV myocardium were included in the analysis [5,6].
Per patient analysis
Following manual rigid motion-correction, a circular
region of interest (ROI) was drawn in the basal LV cavity
in diastole, to derive the arterial input function (AIF).
The same (diastolic) AIF was used for both systolic and
diastolic estimates of MBF in order to avoid potential
variations in the AIF between phases with subsequent
effects on MBF estimation [8].
A whole-heart myocardial region of interest (ROI)
excluding any dark-rim artifact was drawn for both sys-
tolic and diastolic perfusion images (covering all slices
containing myocardium). Signal intensity–time data were
converted to concentration-time data by subtracting the
baseline signal, and global MBF was estimated at stress
and rest using constrained deconvolution with a delayed
Fermi-model applied to the first pass [9,12,13]. MPR was
calculated as stress MBF divided by rest MBF.
Per territory analysis
The above analysis was repeated on a per territory basis
using the 17-segment AHA model adjusted for coronary
dominance [14]. For this, all slices from an individual
patient were first visually allocated to basal, mid or
apical sections of the model. For each perfusion terri-
tory, a myocardial ROI was then outlined including all
segments pertaining to that territory across all slices
according to the 17-segment AHA model. MBF and
MPR estimates were obtained using the same algorithm
as for the whole-heart ROI.
Intra-observer and inter-observer variability
Thirty random territories were re-analyzed 1 month
later by the same observer (M.M.) and by a second ob-
server A.K. (2 yrs and 1 yr experience respectively). A.K.
was blinded to the results of all previous analyses.
Quantitative coronary angiography
Quantitative coronary angiography was performed (QCA-
Plus, Sanders Data Systems, Palo Alto, CA, USA) on
anonymised X-ray angiography images (M.M. 6 years
experience in coronary angiography). Significant CAD was
defined as luminal stenosis ≥70% diameter in any of the
main epicardial coronary arteries or their branches with a
diameter of ≥2 mm.
Statistical analysis
Analysis was performed using SPSS 17.0 (SPSS, Chicago,
IL). Data are presented as mean ± SD. Group means were
compared using paired or unpaired Student t-tests; or
within-subjects analysis of variance with Greenhouse-
Geisser correction for multi-sample sphericity, as appro-
priate. Ordinal data were compared using the Wilcoxon
signed-rank test. Receiver-operating characteristic (ROC)
analysis was performed on a per territory basis, to deter-
mine the diagnostic accuracy of MPR to detect significant
CAD. Diagnostic accuracies are presented as area under
the ROC curve (AUC); and were compared between
Figure 1 Acquisition planning. Because of the longitudinal lengthening of the heart from systole to diastole, the position of the mid-diastolic
(red) and end-systolic perfusion stacks (yellow) (12 slices each) were individually planned from the chosen diastolic (Panel A) and systolic
(Panel B) 4-chamber cine frames. Panel C shows both stacks superimposed on the chosen end-systolic frame.
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systole and diastole using methods described by Delong
and Delong. Optimal MPR cut-off values, for both cardiac
phases, were defined as values that maximised the sum of
sensitivity and specificity. A secondary ROC analysis was
performed to evaluate the diagnostic accuracy of stress
MBF diastolic/systolic ratio. To assess reproducibility, the
coefficients of variation (CoV) for intra- and inter-obser-
ver measurements were calculated. Because three coron-
ary territories were examined per patient, the intra-cluster
correlation coefficient (ICC) was calculated for MPR
estimates to determine the design effect and the need
to adjust data for clustering. All statistical tests were 2-
tailed and a p value <0.05 was considered significant.
Results
Study population
Five of the 40 recruited patients were excluded: 3
because of claustrophobia and 2 owing to technical prob-
lems (1 mistimed contrast injection; 1 significantly altered
patient position between stress and rest scans). A total of
35 patients (105 coronary territories) were therefore
available for analysis. Table 1 shows the baseline patient
characteristics. QCA confirmed significant CAD in 20
patients (57%) and 38 coronary territories (36%). Only 3
patients had evidence of MI on LGE imaging (the same 3
patients with a clinical history of MI), and this involved
only 3 of the 105 territories analysed. Figure 2 shows an
example of the stress perfusion images acquired in a
patient with significant CAD.
Image quality
Overall image quality was better in systole than in dia-
stole (median image quality score: 3 vs. 2 respectively;
p = 0.002). In diastole, there was a greater frequency
of dark-rim artifact (19 patients [54%] vs. 9 patients
[26%] and a higher overall artifact score compared to sys-
tole (median scores: 1 vs. 0 respectively; p < 0.0001).
In 5 patients (14%), perfusion images (both cardiac
phases) were affected by k-t reconstruction artifacts at
stress and/or rest due to respiratory motion, but all of
these artifacts occurred at the end of the breath-hold
and did not affect analysis of the first-pass perfusion
images.
Myocardial blood flow estimation
Estimates of MBF and MPR for both cardiac phases are
seen in Tables 2, 3 and 4. On per patient (n = 35) and
per territory analysis (n = 105), mean resting MBF was
similar in both cardiac phases (all p values > 0.05); but
mean stress MBF and MPR were significantly greater in
diastole than systole (all p values <0.001). These rela-
tionships existed in normal and CAD subgroups, as well
as overall (all p values <0.01) (Tables 2, 3, 4). In both
cardiac phases, stress MBF and MPR were significantly
lower in the presence of CAD than in normal patients
(all p values < 0.01) or normal territories (all p values <
0.0001) (Tables 2, 3, 4).
Analysis of the normal patient group (n = 15) found no
significant regional differences in stress MBF, rest MBF
or MPR between the LAD, LCX or RCA perfusion terri-
tories in both phases (all p values <0.05) (Table 5).
Based on MPR estimates, the ICC for this study was low
(r1 =0.09 [95% CI: -0.25 to 0.41]) with a design effect of
1.18 where cluster size = 3. This shows that the study
design of using 3 ‘related’ coronary territories per patient
(n = 35) to derive a sample size of 105 coronary territories
does not significantly diminish statistical power.
Diagnostic performance
Stress MBF
On a per territory analysis (n = 105), the use of stress
MBF alone had a high overall diagnostic accuracy for the
detection of CAD - which was similar in both cardiac
phases (AUC = 0.95 for both; p = 0.70). The optimal
stress MBF cut-off value was 2.31 ml/min/g for systole
and 2.60 ml/min/g for diastole. At these thresholds, the
sensitivity and specificity were 92% and 93% respectively
for systole; and 95% and 96% for diastole. There was no
significant difference between the diagnostic accuracy of
Table 1 Patient characteristics
Parameter Data (n = 35)
Age (yrs ± SD) 62 ± 8
Sex, n (%)
Male 26 (74)
Female 9 (26)
Risk factors, n (%)
Hypertension 18 (51)
Hypercholesterolemia 19 (54)
Diabetes Mellitus 6 (17)
Smoking 14 (40)
Previous MI 3 (9)
Previous PCI 3 (9)
Angiography findings, n (%) *
No significant disease 15 (43)
One-vessel disease 6 (17)
Two-vessel disease 10 (29)
Three -vessel disease 4 (11)
LAD disease 17 (49)
LCX disease 10 (29)
RCA disease 11 (31)
*Significant disease defined as coronary stenosis ≥70% on quantitative
coronary analysis.
MI =myocardial infarction; PCI = percutaneous coronary intervention; LAD = left
anterior descending coronary artery; LCX = left circumflex coronary artery;
RCA = right coronary artery.
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MPR or stress MBF alone for either cardiac phase (both
p values >0.05) (Figure 3).
MPR
On per territory analysis (n = 105), MPR also had a high
overall diagnostic accuracy for the detection of significant
CAD, and this was similar in both cardiac phases (AUC,
systole: 0.92 vs. diastole: 0.94; p = 0.41) (Figure 3). The
optimal MPR cut-off value was 1.75 for systole and 2.02
for diastole (Figure 4). At these thresholds, the sensitivity
and specificity were 82% and 93% respectively for systole;
and 87% and 94% for diastole. The diagnostic accuracy of
Figure 2 Case example: 3D-perfusion CMR in systole and diastole. This example shows 3D-perfusion CMR in a 75-year-old man with angina.
Stress-induced perfusion defects are seen infero-laterally from base to apex and antero-laterally from mid-ventricle to apex in both diastole and
systole. However, perfusion defects are difficult to discern from dark-rim artifact in diastole and are more clearly delineated with systolic acquisition.
Late-gadolinium enhancement imaging did not reveal any myocardial infarction. X-ray coronary angiography revealed 80% stenosis of a large diagonal
branch and significant proximal disease in a large dominant left circumflex artery.
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MPR to detect CAD in each of the 3 coronary territories
is shown in Table 6 and no significant differences were
seen between cardiac phases.
Diastolic/systolic stress MBF ratio
The diastolic/systolic stress MBF ratio was significantly
lower for territories with CAD than in normal territories
(1.07 ± 0.06 vs. 1.17 ± 0.11; p < 0.0001). On ROC analysis,
the diagnostic accuracy (AUC) of this ratio to detect
significant CAD was 0.79. The optimal cut-off value for
the ratio was 1.10 which gave a sensitivity of 82% and
specificity of 76% (Figure 5).
Reproducibility
Stress MBF
The mean absolute difference between intra-observer mea-
surements of stress MBF was similar in systole and diastole
(0.33 ± 0.14 vs. 0.35 ± 0.16; p = 0.18); and the correspond-
ing CoVs were 16% and 17% respectively. The mean abso-
lute difference between inter-observer measurements of
stress MBF was also similar in systole and diastole (0.41 ±
0.22 vs. 0.45 ± 0.20; p = 0.11) with corresponding CoVs of
18% for both.
MPR
The mean absolute difference between intra-observer
measurements of MPR was similar in systole and diastole
(0.30 ± 0.15 vs. 0.36 ± 0.13; p = 0.09); and the correspond-
ing CoVs were both 18%. The mean absolute difference
between inter-observer measurements of MPR was also
similar in systole and diastole (0.35 ± 0.17 vs. 0.41 ± 0.15;
p = 0.07) with corresponding CoVs of 20% and 21%
respectively.
Discussion
The main findings of this study are 1) quantitative 3D-
perfusion CMR is feasible and has a high diagnostic
accuracy for the detection of CAD; 2) similar to 2D
studies, estimates of stress MBF and MPR from 3D data
are significantly greater in diastole than systole; and 3) the
diastolic dominance of stress MBF estimates is reduced in
ischemia.
One of the limitations of myocardial perfusion imaging
and standard visual interpretation is the dependence on
a reference area of normal perfusion. This is a particular
impediment in diffuse or balanced multi-vessel disease.
This limitation can be avoided by using absolute quantifi-
cation of MBF [15]. At present, the most robust technique
to quantify MBF noninvasively is positron emission tom-
ography (PET) - but its wide-spread clinical application
has been slowed by limited access [16]. PET imaging also
involves exposure to ionizing radiation, and its spatial
resolution limits evaluation of transmural flow differences
in normal thickness myocardium.
Over the last decade, several animal, normal volunteer
and patient studies have validated the use of CMR for
absolute MBF quantification against microsphere and
invasive coronary flow reserve measurements [17-19]. Fur-
thermore, several clinical studies have demonstrated high
diagnostic accuracy of CMR derived estimates of absolute
MBF and MPR against both QCA and fractional flow
reserve [9,13,15,20,21]. Nonetheless, the lack of complete
myocardial coverage has been a significant limitation of
conventional 2D-perfusion CMR for this purpose.
This study has for the first time demonstrated the feasi-
bility of quantitative whole-heart 3D-perfusion CMR.
Shin et al have previously reported semi-quantitative
measures (time-intensity curve indices) of resting
Table 2 Estimates of MBF and MPR from 3D perfusion CMR - per patient analysis
Stress MBF (ml/min/g) Rest MBF (ml/min/g) MPR
Systole Diastole p Systole Diastole p Systole Diastole p
Normal (n = 15) 2.88 ± 0.32 3.47 ± 0.41 p < 0.0001 1.28 ± 0.17 1.26 ± 0.15 p = 0.45 2.27 ± 0.37 2.78 ± 0.40 p < 0.0001
CAD (n = 20) 2.32 ± 0.42 2.53 ± 0.47 p < 0.0001 1.32 ± 0.19 1.28 ± 0.21 p = 0.06 1.82 ± 0.54 2.08 ± 0.74 p < 0.001
Overall (n = 35) 2.56 ± 0.47 2.93 ± 0.65 p < 0.0001 1.30 ± 0.18 1.27 ± 0.19 p = 0.06 2.01 ± 0.08 2.38 ± 0.05 p < 0.0001
All values expressed as mean ± SD. Coronary artery disease (CAD) defined as stenosis ≥70%. CMR = cardiovascular magnetic resonance; MBF = myocardial blood
flow; MPR = myocardial perfusion reserve.
Table 3 Estimates of MBF and MPR from 3D-perfusion CMR - per territory analysis
Stress MBF (ml/min/g) Rest MBF (ml/min/g) MPR
Systole Diastole p Systole Diastole p Systole Diastole p
Normal (n=67) 2.75 ± 0.42 3.21 ± 0.50 p < 0.0001 1.24 ± 0.15 1.25 ± 0.15 p = 0.27 2.26 ± 0.43 2.59 ± 0.44 p < 0.0001
CAD (n=38) 1.98 ± 0.41 2.13 ± 0.55 p < 0.0001 1.24 ± 0.15 1.26 ± 0.14 p = 0.20 1.63 ± 0.14 1.72 ± 0.19 p < 0.01
Overall (n=105) 2.47 ± 0.55 2.82 ± 0.71 p < 0.0001 1.24 ± 0.15 1.25 ± 0.15 p = 0.10 2.03 ± 0.52 2.27 ± 0.61 p < 0.0001
All values expressed as mean ± SD. Coronary artery disease (CAD) defined as stenosis ≥70%. CMR = cardiovascular magnetic resonance; MBF = myocardial blood
flow; MPR = myocardial perfusion reserve.
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myocardial perfusion from a 3D acquisition in 3 healthy
volunteers - but no stress acquisition or absolute MBF
quantification was performed [10]. The MBF values de-
rived with 3D-perfusion CMR in normal patients in the
present study are comparable to values from PET studies
and the previous CMR literature [22,23]. For example, in a
large study of 160 healthy men and women with PET, the
mean resting MBF was 0.98 ± 0.23 ml/min/g (range 0.59-
2.05 ml/min/g) and the mean stress MBF was 3.77 ±
0.85 ml/min/g (range 1.85-5.99 ml/min/g) [23]. Intra- and
inter-observer reproducibility for stress MBF and MPR
in our study was also similar to that seen in 2D-per-
fusion CMR and PET studies [24,25].
The finding of lower estimates of stress MBF in systole
compared to diastole is consistent with the expected phy-
siology and a number of previous studies. Physiologically,
one explanation is that during systole, the effect of
adenosine-mediated vasodilatation is diminished by the
compression of intramyocardial vessels [26]. Two previous
2D-perfusion CMR studies have shown the same
phasic differences with higher stress MBF estimates in
diastole, but no difference between the phases at rest [8,9].
One previous 3D-perfusion CMR study confirmed similar
semi-quantitative measures of resting myocardial perfu-
sion between systole and diastole - but no stress perfusion
was performed [10]. Our study has now demonstrated
that these phasic differences are also seen with 3D-
perfusion CMR quantification and underline the import-
ance of stating the phase of acquisition in future studies to
allow comparison in the literature.
Quantitative analysis with MPR yielded high diagnostic
accuracies in both systole and diastole (AUC: 0.92 and
0.94 respectively). The optimal MPR cut-off values for
detecting significant CAD (1.75 for systole and 2.02 for
diastole) were within the range of 1.50–2.06 reported in
previous 2D-perfusion CMR studies [9,13,20,21,27]. Re-
cently, in 2D-perfusion CMR, Huber et al (n = 31) showed
that the use of stress MBF alone had a similar diagnostic
accuracy as MPR (AUC 0.92 vs. 0.84 respectively; p < 0.18)
[11]. Our study has shown a similar finding in 3D-
perfusion CMR and the implication is that a rest perfusion
sequence could potentially be omitted in quantitative
studies, thus reducing both scanning and post-processing
times without a loss in diagnostic yield (Figure 3).
The noted reduction in diastolic/systolic stress MBF ratio
in territories with CAD is consistent with previous invasive
studies measuring coronary flow velocity throughout the
cardiac cycle [28]. The loss of diastolic dominance has
been explained by the increased influence of a significant
stenosis on flow during periods of low vascular resistance
Table 4 Regional estimates of MBF and MPR - per territory (n=105)
Normal CAD
Systole Diastole p Systole Diastole p
Stress MBF (ml/min/g)
LAD 2.91 ± 0.35 3.43 ± 0.46 p<0.0001 2.11 ± 0.46 2.28 ± 0.52 p<0.001
LCX 2.63 ± 0.33 3.10 ± 0.44 p<0.0001 1.90 ± 0.28 2.04 ± 0.28 p<0.01
RCA 2.77 ± 0.51 3.16 ± 0.55 p<0.0001 1.85 ± 0.39 1.97 ± 0.40 p<0.0001
Rest MBF (ml/min/g)
LAD 1.26 ± 0.17 1.30 ± 0.17 p=0.10 1.21 ± 0.12 1.23 ± 0.12 p=0.52
LCX 1.26 ± 0.17 1.24 ± 0.13 p=0.56 1.22 ± 0.14 1.20 ± 0.10 p=0.27
RCA 1.20 ± 0.13 1.23 ± 0.15 p=0.28 1.28 ± 0.13 1.24 ± 0.16 p=0.26
MPR
LAD 2.35 ± 0.42 2.68 ± 0.48 p<0.0001 1.75 ± 0.37 1.87 ± 0.51 p=0.02
LCX 2.12 ± 0.35 2.52 ± 0.38 p<0.0001 1.58 ± 0.32 1.72 ± 0.29 p<0.01
RCA 2.33 ± 0.51 2.59 ± 0.48 p<0.001 1.46 ± 0.34 1.60 ± 0.34 p<0.01
All values expressed as mean ± SD. Coronary artery disease (CAD) defined as stenosis ≥70%. MBF = myocardial blood flow; MPR = myocardial perfusion reserve;
LAD = left anterior descending coronary artery; LCX = left circumflex coronary artery; RCA= right coronary artery.
Table 5 Comparison of regional MBF and MPR estimates –
in normal patients (n=15)
Perfusion territory
LAD LCX RCA p
Stress MBF (ml/min/g)
Systole 2.95 ± 0.36 2.66 ± 0.29 2.88 ± 0.46 P=0.11
Diastole 3.51 ± 0.46 3.19 ± 0.27 3.27 ± 0.47 P=0.10
Rest MBF (ml/min/g)
Systole 1.27 ± 0.17 1.29 ± 0.19 1.20 ± 0.13 p=0.25
Diastole 1.29 ± 0.17 1.27 ± 0.14 1.22 ± 0.15 p=0.47
MPR
Systole 2.36 ± 0.42 2.10 ± 0.32 2.45 ± 0.53 P=0.06
Diastole 2.76 ± 0.45 2.54 ± 0.33 2.71 ± 0.48 P=0.27
All values expressed as mean ± SD. MBF = myocardial blood flow; MPR =
myocardial perfusion reserve; LAD = left anterior descending coronary artery;
LCX = left circumflex coronary artery; RCA= right coronary artery.
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and low intramyocardial tension (diastole); as compared
with that during periods of high vascular resistance and
high intramyocardial tension (systole) [29]. As such, the
diastolic/systolic stress MBF ratio is a novel diagnostic
index with moderate diagnostic accuracy (AUC= 0.79) –
and this may warrant further evaluation in future studies.
In our quantitative study, both phases had similar
diagnostic performance and reproducibility. However,
similar to previous 2D studies, diastole was more prone
to dark-rim artifact with an adverse effect on image
quality; and this is thought to relate to the thinner myo-
cardium, making it more prone to partial volume effects
at a given spatial resolution [9]. For this reason, as well
as the fact that contour delineation is easier in systole
because of the thicker myocardium, we would suggest
systole as the preferred phase for 3D-perfusion CMR
acquisition - particularly for quantitative studies. Although
analysis time was not specifically measured, each 3D per-
fusion dataset took approximately 20 min to analyse on a
per patient basis (including stress and rest analyses for
either the systolic or diastolic cardiac phase). Quantifying
3D-perfusion CMR can be simpler than quantifying con-
ventional 2D datasets, because as in our study, fewer
dynamic images are often acquired and there is a degree
Figure 3 Diagnostic accuracy of quantitative 3D-perfusion CMR. (A) Receiver-operator characteristic curves shows a high diagnostic accuracy
in both systole and diastole for MPR (area under curve [AUC]: 0.92 vs. 0.94 respectively; p = 0.41). (B) Use of stress MBF alone also had a high
diagnostic accuracy in both cardiac phases (AUC: 0.95 for both; p = 0.70) and in fact there was no significant difference compared to MPR (p > 0.05 for
both cardiac phases).
Figure 4 Myocardial perfusion reserve threshold. The scatter-plots show myocardial perfusion reserve (MPR) values from normal and significantly
diseased perfusion territories with both systolic and diastolic 3D-perfusion CMR (x =mean value, solid line =median value). The optimal MPR cut-off
values determined by receiver-operating characteristic analysis are also plotted (dashed lines, 1.75 for systole and 2.02 for diastole).
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of temporal filtering due to the undersampling in the tem-
poral domain which reduces the amount of time-consum-
ing manual motion correction required.
Finally, there is considerable scope for quantitative
perfusion CMR in clinical practice and therefore demon-
strating the feasibility of 3D whole-heart coverage and
quantification is important. Nonetheless, there still remain
a number of other limitations that hold back the wider clin-
ical adoption of quantitative perfusion CMR. The current
lack of standardisation in image acquisition, contrast dosing
protocols, post-processing, mathematical modelling and
interpretation is addressed by an international standard-
isation task force [30,31]. There is also no widely available
and validated analysis software for quantitative analysis of
perfusion CMR data and research groups generally use
in-house solutions. Analysis can be time-consuming, pre-
cluding routine clinical application. Finally, the incremen-
tal value of quantitative analysis of myocardial perfusion
CMR analysis needs to be shown in large clinical studies.
Study limitations
The spatio-temporal undersampling methods required for
3D data acquisition are sensitive to respiratory motion,
cardiac arrhythmia and low-pass temporal filtering - all of
which pose additional challenges to quantitative assess-
ment. Low-pass temporal filtering in particular may lead
to underestimation of MBF. We reduced these limitations
by use of the constrained k-t PCA framework for image
reconstruction, which has been shown to improve tem-
poral fidelity, permitting robust measurements of MBF at
very high acceleration factors [32]. The latter is also less
prone to respiratory artifact as temporal basis functions
are derived based on the low-resolution training data
acquired in every heartbeat [2].
Although MPR performed well in our study, perfusion
imaging is a measurement of the hemodynamic conse-
quences of a stenosis rather than its anatomy, and there-
fore our use of QCA is an imperfect reference standard.
Following this initial feasibility study, future validation
against fractional flow reserve is planned in a larger
clinical population. Another limitation, common to many
previous studies, is the potential effect of data clustering
as three perfusion territories are examined per patient
[20,27]. However, the design effect of this was low (1.18)
owing to a small ICC and cluster size.
Finally, the model used for estimating MBF assumes a
linear relation between signal and contrast agent con-
centration i.e. ignoring saturation effects in the LV blood
pool which can lead to underestimation of MBF [33].
This is particularly relevant as we used a relatively high
contrast agent dose of 0.075 mmol/kg bodyweight to be
consistent with previous 3D-perfusion CMR studies.
Proposed solutions include the use of a non-linear signal
model combined with precontrast T1-mapping and/or
the use of a small pre-bolus to measure the AIF. There
is currently no evidence that either of these potential
solutions actually leads to improved diagnostic accuracy
for the detection of CAD in the clinical setting. In fact
Table 6 Diagnostic accuracy of quantitative 3D-perfusion
CMR–per territory (n=105)
AUC for MPR
Systole Diastole P
All territories 0.92 (0.87-0.98) 0.94 (0.88-0.99) p=0.41
LAD 0.89 (0.78-0.99) 0.90 (0.79-1.00) p=0.76
LCX 0.88 (0.77-0.99) 0.98 (0.93-1.00) p=0.34
RCA 0.92 (0.86-0.99) 0.98 (0.93-1.00) p=0.50
Values are area under the curve (AUC) and (95% confidence interval). LAD =
left anterior descending coronary artery; LCX = left circumflex coronary artery;
RCA= right coronary artery.
Figure 5 Diastolic/systolic stress myocardial blood flow ratio. The ratio of diastolic to systolic myocardial blood flow at stress was
significantly lower for territories with coronary artery disease (CAD) than in normal territories (1.07 ± 0.06 vs. 1.17 ± 0.11; p < 0.0001). On
receiver-operator characteristic analysis, the diagnostic accuracy (area under the curve) of this ratio to detect significant CAD was 0.79. The
optimal cut-off value for the ratio was 1.10, which gave a sensitivity of 82% and specificity of 76%.
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the only study directly addressing this question came to
the opposite conclusion i.e. the use of a pre-bolus AIF
was found to reduce diagnostic accuracy compared to a
single-bolus approach [34].
Conclusions
We have shown that quantitative 3D-perfusion CMR is
feasible and can be used to detect CAD with high diagnos-
tic accuracy. In addition, we have found that there are sig-
nificant differences in systolic and diastolic MBF estimates.
Both cardiac phases provide comparable diagnostic yield,
albeit at different thresholds. Because systolic images had
fewer artifacts and higher image quality, systole may be the
preferred phase for acquisition of 3D perfusion data.
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